Creo Medical Group PLC
F:1RC

Watchlist Manager
Creo Medical Group PLC Logo
Creo Medical Group PLC
F:1RC
Watchlist
Price: 0.128 EUR
Market Cap: €46.2m

Wall St Price Targets

1RC Price Targets Summary
Creo Medical Group PLC

Wall Street analysts forecast 1RC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 1RC is 0.496 EUR with a low forecast of 0.393 EUR and a high forecast of 0.715 EUR.

Lowest Forecast
Price Target
0.393 EUR
207% Upside
Average Forecast
Price Target
0.496 EUR
288% Upside
Highest Forecast
Price Target
0.715 EUR
459% Upside
Creo Medical Group PLC Competitors:
Price Targets
XPEL
Xpel Inc
24% Upside
PMT
PennyMac Mortgage Investment Trust
25% Upside
RVSB
Riverview Bancorp Inc
31% Upside

Revenue
Forecast

N/A
Past Growth
63% / Year
Estimated Growth
Estimates Accuracy
-44%
Average Miss
N/A
Past Growth
63% / Year
Estimated Growth
Estimates Accuracy
-44%
Average Miss

The compound annual growth rate for Revenue over the next 6 years is 63%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
16%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
16%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-51%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-51%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 1RC's stock price target?
Price Target
0.496 EUR

According to Wall Street analysts, the average 1-year price target for 1RC is 0.496 EUR with a low forecast of 0.393 EUR and a high forecast of 0.715 EUR.

What is the Revenue forecast for Creo Medical Group PLC?
Projected CAGR
63%

The compound annual growth rate for Revenue over the next 6 years is 63%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett